Rodos BioTarget GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Rodos BioTarget GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10828
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Rodos BioTarget GmbH (RBT) is a biopharmaceutical company that develops drug delivery platforms. The company provides products such as targosphere, targobiotics and targovir. Its targosphere finds application in treating various infectious diseases such as virus caused HCV and hepatitis c and HIV and AIDS; and bacteria caused tuberculosis, legionellosis, methicillin-resistant staphylococcus aureus, and others. RBT’s technology platform targosphere enables the targeted delivery of active agents and vaccines into antigen-presenting cells. The company’s targovir also develops CLR-TS for targeted delivery of antivirals to eradicate intracellular viral reservoirs in the form of infectious virions and proviral DNA integrated into the host cell’s genome. It has partnership with university and institute. RBT is headquartered in Hannover, Germany.

Rodos BioTarget GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Rodos BioTarget GmbH, Medical Devices Deals, 2012 to YTD 2018 9
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Rodos BioTarget Raises US$3.4 Million In Growth Financing 11
Partnerships 12
Rodos Biotarget and Pharis Biotec Enter into Co-Development Agreement 12
Rodos BioTarget Enters into Agreement with Biozeus 13
Rodos BioTarget GmbH – Key Competitors 14
Rodos BioTarget GmbH – Key Employees 15
Rodos BioTarget GmbH – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Rodos BioTarget GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
Rodos BioTarget GmbH, Medical Devices Deals, 2012 to YTD 2018 9
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Rodos BioTarget Raises US$3.4 Million In Growth Financing 11
Rodos Biotarget and Pharis Biotec Enter into Co-Development Agreement 12
Rodos BioTarget Enters into Agreement with Biozeus 13
Rodos BioTarget GmbH, Key Competitors 14
Rodos BioTarget GmbH, Key Employees 15

List of Figures
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Rodos BioTarget GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Rodos BioTarget GmbH, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Rodos BioTarget GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nine Dragons Paper (Holdings) Ltd:企業の戦略・SWOT・財務分析
    Nine Dragons Paper (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report Summary Nine Dragons Paper (Holdings) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • J&P – Avax Sa
    J&P - Avax Sa - Strategy, SWOT and Corporate Finance Report Summary J&P - Avax Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • 4D Molecular Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary 4D Molecular Therapeutics Inc (4D Molecular Therapeutics) focuses on the discovery and development of targeted and proprietary AAV gene therapy vectors and therapeutic products. The company developed a discovery platform, Directed Vector Evolution, which empowers to create customized gene de …
  • Jubilant Biosys Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Jubilant Biosys Ltd (Jubilant Biosys), a subsidiary of Jubilant Life Sciences Ltd, is a provider of drug discovery and development solutions. The company offers functional discovery services such as toxicology models, computational chemistry, medicinal chemistry, structural biology, drug met …
  • Leidos Holdings Inc:企業のM&A・事業提携・投資動向
    Leidos Holdings Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Leidos Holdings Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Reliance Capital Ltd:企業の戦略・SWOT・財務分析
    Reliance Capital Ltd - Strategy, SWOT and Corporate Finance Report Summary Reliance Capital Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • China Pioneer Pharma Holdings Ltd (1345):企業の財務・戦略的SWOT分析
    Summary China Pioneer Pharma Holdings Ltd (Pioneer Pharma) is an investment holding company that markets and promotes pharmaceutical products and medical devices. The company offers pharmaceutical products such as anti-inflammatory medicines, pain management, orthopedics, opthalmology, chronic obstr …
  • Alcon Inc (ALC):企業の製品パイプライン分析
    Summary Alcon Inc (Alcon) develops and manufactures devices in the field of ophthalmology. The company’s portfolio encompasses contact lenses and surgical products, including implantables, consumables and surgical equipment. The company's products are indicated for the treatment of various condition …
  • Inter Pipeline Ltd (IPL):企業の財務・戦略的SWOT分析
    Inter Pipeline Ltd (IPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Eisai Inc:企業の戦略的SWOT分析
    Eisai Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Kenya Electricity Generating Co Ltd (KGEN):電力:M&Aディール及び事業提携情報
    Summary Kenya Electricity Generating Co Ltd (KenGen) is an electricity generation utility. It produces power from hydro, geothermal, thermal, and wind sources. Under power purchase agreements, the company sells power to customers on wholesale basis. Kenya Power and Lighting Company Limited is the au …
  • AnaMar AB-医療機器分野:企業M&A・提携分析
    Summary AnaMar AB (AnaMar), a subsidiary of Koncentra Holding AB, discovers, develops and commercializes therapeutic strategies to treat debilitating inflammation, fibrosis and pain. The company develops drug candidates from several chemical classes that concentrates on the receptors and shows poten …
  • iBio Inc (IBIO)-製薬・医療分野:企業M&A・提携分析
    Summary iBio Inc (iBio) is a biotechnology company that develops and manufactures plant made pharmaceutical products. The company provides products such as biotherapeutics and vaccines. It uses its ibiolaunch platform, which is a transformative technology for the production of monoclonal antibodies, …
  • Acuity Brands Inc (AYI)-エネルギー分野:企業M&A・提携分析
    Summary Acuity Brands, Inc. (Acuity Brands) provides lighting and building management solutions and services. The company offers lighting solutions including devices such as luminaires, lighting controls, lighting components, power supplies, prismatic skylights, and integrated lighting systems. It a …
  • Steppe Cement Ltd:企業の戦略・SWOT・財務情報
    Steppe Cement Ltd - Strategy, SWOT and Corporate Finance Report Summary Steppe Cement Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Vedanta Ltd:企業のM&A・事業提携・投資動向
    Vedanta Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Vedanta Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Salt Lake Potash Ltd (SO4):企業の財務・戦略的SWOT分析
    Summary Salt Lake Potash Ltd (Salt Lake Potash), formerly Wildhorse Energy Ltd, is a mining and mineral exploration and development company that develops and evaluates underground coal gasification projects and uranium deposits. The company operates exploration and mining activities with geographic …
  • Western Digital Corporation:企業の戦略・SWOT・財務情報
    Western Digital Corporation - Strategy, SWOT and Corporate Finance Report Summary Western Digital Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • BaroFold Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary BaroFold Inc (BaroFold) is a biotechnology company that provides protein herapeutics for bio-pharmaceutical companies, research institutions, and government agencies. The company applies its Pressure Enabled Protein Manufacturing (PreEMT) technology that improves the tolerability, efficacy a …
  • National Insurance Corporation of Eritrea Share Company:企業の戦略的SWOT分析
    National Insurance Corporation of Eritrea Share Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆